title: Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
authors.forename: Andrea
authors.initials: A
authors.lastname: Santamato
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Ianieri
authors.forename: Maurizio
authors.initials: M
authors.lastname: Ranieri
authors.forename: Marisa
authors.initials: M
authors.lastname: Megna
authors.forename: Francesco
authors.initials: F
authors.lastname: Panza
authors.forename: Pietro
authors.initials: P
authors.lastname: Fiore
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Megna
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000150:complications*; D010306:Parotid Gland; D012798:Sialorrhea / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A